Basilea Pharmaceutica
BSLN.SW
#6509
Rank
A$0.85 B
Marketcap
$70.32
Share price
0.50%
Change (1 day)
13.58%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2023: A$19.05 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are A$0.18 Billion. In 2023 the company made an earning of A$19.05 Million a decrease over its 2022 earnings that were of A$20.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2023

Annual earnings

Year Earnings Change
2023A$19.05 M-5.02%
2022A$20.06 M-276.18%
2021-A$11.39 Million-55.31%
2020-A$25.49 Million-28%
2019-A$35.4 Million-27.06%
2018-A$48.53 Million62.13%
2017-A$29.93 Million-60.94%
2016-A$76.62 Million-19.67%
2015-A$95.38 Million48.25%
2014-A$64.34 Million12.95%
2013-A$56.96 Million-35.16%
2012-A$87.85 Million-5.75%
2011-A$93.21 Million-152.57%
2010A$0.17 B-199.59%
2009-A$0.18 Billion-15.54%
2008-A$0.22 Billion22.84%
2007-A$0.18 Billion60.07%
2006-A$0.11 Billion85.69%
2005-A$57.74 Million-43.04%
2004-A$0.11 Billion47.04%
2003-A$68.94 Million-33.1%
2002-A$0.11 Billion